3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Myeloid
1
Classical hematology
1
Conditions
Myeloproliferative Disorders
2
Multiple Myeloma
2
Leukemia, Myeloid, Acute
2
Venous Thromboembolism
1
Thrombophilia
1
Thrombocytopenia
1
Thrombocythemia, Essential
1
Testicular Neoplasms
1
Sleep Apnea, Obstructive
1
Sezary Syndrome
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Neuroblastoma
1
Neoplasms
1
Myeloproliferative Syndrome, Transient
1
Myelodysplastic Syndromes
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Leukopenia
1
Leukemia, Neutrophilic, Chronic
1
Leukemia, Myelomonocytic, Chronic
1
Interventions
fludarabine phosphate
6
Whole-Body Irradiation
6
Melphalan
5
Stem Cell Transplantation
4
Peripheral Blood Stem Cell Transplantation
4
Mycophenolic Acid
4
Antibodies
4
Cyclophosphamide
3
thymoglobulin
2
Tacrolimus
2
Methotrexate
2
Cyclosporine
2
Busulfan
2
Antilymphocyte Serum
2
Alemtuzumab
2
merphos
1
fludarabine
1
Transplantation, Homologous
1
Thiotepa
1
Sirolimus
1
Rituximab
1
Observation
1
Muromonab-CD3
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Etoposide
1
Drug Therapy
1
Cyclosporins
1
Basiliximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hemoglobinuria, Paroxysmal
×
Observation
×
Myeloid
×
Clear all
NCT07108023
2025-08-06
EHPVO-HEM
Assiut University
Not yet recruiting
115 enrolled